How to forecast in a Covid-19 world?

14th September 2020
The COVID-19 pandemic has brought fast moving, changing variables placing extraordinary strains and uncertainty on society as whole. The changes in primary and secondary care globally have and will continue to affect future pharmaceutical forecasts for in-market and new product launches. High levels of unpredictability…
Read More

J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market

12th August 2020
J+D’s approach and the model has given the team greater confidence in the outputs and subsequent decisions they will have to make in taking the product forward.
Read More

J+D Forecasting Changed the Forecasting Approach of a Global Bio Tech Forever

23rd July 2020
One of the world’s first global biotechnology companies a leader, in innovative scientific research in neurological diseases approached J+D Forecasting with a set of forecasting challenges.
Read More

Improve efficiencies in your long-range/strategic planning

21st July 2020
Here we offer insight into how you can improve efficiencies in your long range strategic planning by moving to cloud-based software solutions.
Read More

Best practice tips for visualizing your pharma forecast

20th July 2020
Here we offer insight into the best practises for visualising your forecast, from thinking about your audience to interacting with data.
Read More

How to choose the most appropriate trending approach for a sales forecast

18th June 2020
When you are creating a sales-based forecast there can be a wide range of sophisticated forecasting methodologies available to you.
Read More

Forecasting by biomarker, not tumour type

18th June 2020
If you are forecasting for an asset across multiple tumour types, forecasting using biomarkers may be a favourable approach for you.
Read More

The Unique Challenges and Opportunities of Forecasting for Orphan Diseases

15th June 2020
An article written by David James, IPI - International Pharmaceutical Industry
Read More

Running a risk analysis on consolidated revenues

15th June 2020
This post will look at Epidemiology Forecasting, and running a risk analysis on consolidated revenues.
Read More

Accounting for chronic patients in your forecast

15th June 2020
This post will look at Oncology Forecasting, and accounting for chronic patients in your forecast.
Read More

Linking an NPV to your sales forecast

15th April 2020
Learn how to link your forecast to a Profit & Loss account, determining Net Present Value can make for much better evaluation of opportunities.
Read More

Top 5 forecasting tips in Oncology

17th April 2019
Contact us for a consultation  Find more J+D Forecasting insights 1 – All Change   Consider the stability of the market when deciding on the methodology. Patient flow models are accurate and provide a great deal of insight, however, they’re only really necessary when there is…
Read More